Skip to content

Comparison between cubital tunnel release and cubital tunnel obliteration for the treatment of cubital tunnel syndrome: randomized controlled trial

Comparison between cubital tunnel release and cubital tunnel obliteration for the treatment of cubital tunnel syndrome: randomized controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0008064
Enrollment
70
Registered
2023-01-02
Start date
2023-02-14
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Procedure/Surgery : Cubital tunnel release is a mainly used surgical treatment for cubital tunnel syndrome. This surgical treatment's strength is that it is simple and has less artificial manipulation

Sponsors

Asan Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patient whose age is between 18 and 80, clinical findings, physical examination and EMG&NCV findings indicate cubital tunnel syndrome and decides to take surgical treatment between December 2022 and November 2024.

Exclusion criteria

Exclusion criteria: 1) Patients who were surgically treated for cubital tunnel syndrome in past. 2) Patients who have risk factors for peripheral neuropathy including peripheral vascular disease, herniated cervical (lumbar) disc, carpal tunnel syndrome or patients who have risk factors for chronic tenosynovitis including hypothyroidism, rheumatoid arthritis 3) Patients whose follow up duration is less than a year

Design outcomes

Primary

MeasureTime frame
Disabilities of Arm Shoulder and Hand score

Secondary

MeasureTime frame
Visual Analogue Scale score;Boston Carpal Tunnel Syndrome Questionnaire-Symptom score;Boston Carpal Tunnel Syndrome Questionnaire-Function score;Grip strength

Countries

Korea, Republic of

Contacts

Public ContactYoung Ho Shin

Asan Medical Center

123sinyh@gmail.com+82-2-3010-1838

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026